Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other 1Head & Neck 1

Conditions

Mucositis 27Opioid-Induced Constipation 20Constipation 18Head and Neck Neoplasms 14Stomatitis 13Pain 12Neoplasms 7Obesity 6Intestinal Diseases 5Bronchiolitis Obliterans Syndrome 5Oral Ulcer 3Lymphoma, Follicular 3Hematologic Neoplasms 3Chemotherapy-induced Peripheral Neuropathy 3Breast Neoplasms 3Xerostomia 2Venous Thromboembolism 2Tumor Lysis Syndrome 2Thrombocytopenia 2Teratogenesis 2Sexual Dysfunctions, Psychological 2Sexual Dysfunction, Physiological 2Renal Insufficiency 2Prostatic Neoplasms 2Peripheral Nervous System Diseases 2Overweight 2Obesity, Morbid 2Neutropenia 2Myocardial Infarction 2Myelodysplastic Syndromes 2

Interventions

tempol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Ototoxicity × Other × Clear all
NCT03480971 2024-11-20

Treatment of Radiation and Cisplatin Induced Toxicities with Tempol

Matrix Biomed, Inc.

Phase 2 Recruiting
120 enrolled
Other

Ototoxicity, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡